We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Judge Upholds Pfizer’s Sutent Patents Against Mylan ANDA
Federal Judge Upholds Pfizer’s Sutent Patents Against Mylan ANDA
A federal judge has struck down Mylan’s Paragraph IV ANDA challenge against Pfizer’s blockbuster cancer drug Sutent, ruling that the therapy’s patents are not invalid.